Ads by Google
Diabetes patients may benefit from receiving treatment from a groundbreaking research that transfers human embryonic stem cells into insulin releasing cells. The research was conducted by San Diego based biological company Novocell on mice.
Scientists inserted human embryonic stem cells into mice with artificially posed diabetes like symptoms. The mice showed to be developing insulin releasing cells thanks to inserted embryos.
An inexpensive anti-inflammatory drug similar to aspirin, salsalate, may prevent type 2 diabetes by lowering blood glucose and reducing inflammation.
A new diabetes prevention resource is designed to encourage and help faith-based and community organizations get actively involved in deterring preventable diabetes among African-Americans.
The goals of the this diabetes care research include increasing awareness of the gap between current practice and acceptable standards of diabetes care among internists; increasing internists' awareness of what constitutes high quality, evidence-based diabetes care; and providing educational tools to improve diabetes treatment.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
Genaera Corporation announced a poster presentation of preclinical data on trodusquemine for treatment of type 2 diabetes and obesity.
A new study found that 40 percent of pancreatic cancer patients are diagnosed with diabetes prior to their pancreatic cancer diagnosis. The onset of diabetes appears to be many months (in some cases up to two years) prior to cancer diagnosis. This information provides researchers an important clue for earlier detection of pancreatic cancer. The study was published in this month's issue of Gastroenterology.
FDA has approved Daiichi Sankyo's Welchol to improve glycemic control in adults with type 2 diabetes.
BIOSAFE Medical Technologies has announced the development of the first consumer test to evaluate diabetes risk. The Diabetes Risk Assessment test will be marketed exclusively in the United States by Glycemion, Inc.
Resistance to insulin that precedes type 2 diabetes may stem from a "metabolic traffic jam".
In some individuals, the specialized immunoregulatory T-cells may lose their effectiveness and become lazy over time, leading to the onset of type 1 diabetes.
It is hard enough to be under the weather but it is even more difficult to handle being sick if you have diabetes.Runny nose. Upset stomach. Whatever illness it is, it can make you feel miserable. It is hard enough to be under the weather but it is even more difficult to handle being sick if you have diabetes.
Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control In Patients With Type 2 Diabetes
Glucose-Dependent Insulinotropic Receptors, or GDIRs, may improve glucose control in patients with type 2 diabetes.
Missouri Department of Health is recommending two new Internet sites to help Missourians more effectively deal with diabetes.
A popular class of drugs for treating type 2 diabetes is under scrutiny again. A new Canadian study released by the Institute for Clinical Evaluative Sciences (ICES) finds that drugs such as Avandia increase the risk of heart failure, heart attacks and death.
Diabetes poses a serious threat to the black community.
Over the four-year span between 1998 and 2002, community health centers not only improved their processes for managing diabetes, but also saw gains in their patients' health.
Access Pharmaceuticals has demonstrated the ability, using the company's proprietary Cobalamin technology, to significantly reduce glucose levels in an animal model of diabetes.
MBGH releases report on the prevalence, costs and quality of care for patients with Type 2 diabetes.
Amylin Pharmaceuticals, Eli Lilly announced study results from a study of monotherapy injection taken twice daily in drug-naive patients with type 2 diabetes.
Holiday celebrations might have some people feeling jolly, but for the 21 million Americans with diabetes and their families, this time of the year raises challenges and anxiety over what to eat.